Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-4-2
pubmed:abstractText
To evaluate the prevalence of human epidermal growth factor receptor 2 (HER2) gene overexpression in breast cancer patients encountered in Hong Kong and the concordance of HER2 findings from primary immunohistochemistry assays and confirmatory in-situ hybridisation assays.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1024-2708
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
130-5
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18382020-Adult, pubmed-meshheading:18382020-Breast Neoplasms, pubmed-meshheading:18382020-Carcinoma, Ductal, pubmed-meshheading:18382020-Carcinoma, Lobular, pubmed-meshheading:18382020-Cross-Sectional Studies, pubmed-meshheading:18382020-Female, pubmed-meshheading:18382020-Gene Amplification, pubmed-meshheading:18382020-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18382020-Hong Kong, pubmed-meshheading:18382020-Humans, pubmed-meshheading:18382020-Immunohistochemistry, pubmed-meshheading:18382020-In Situ Hybridization, pubmed-meshheading:18382020-In Situ Hybridization, Fluorescence, pubmed-meshheading:18382020-Middle Aged, pubmed-meshheading:18382020-Neoplasm Staging, pubmed-meshheading:18382020-Predictive Value of Tests, pubmed-meshheading:18382020-Receptor, erbB-2, pubmed-meshheading:18382020-Retrospective Studies
pubmed:year
2008
pubmed:articleTitle
HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.
pubmed:affiliation
Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong. tkokyau@gmail.com
pubmed:publicationType
Journal Article, Comparative Study